Roberts Johanna reported tax withholding involving 1,002 shares of Penumbra Inc at $320.91 for −$322k on Nov 15, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
EVP, Gen. Counsel & Secretary
EVP, Gen. Counsel & Secretary
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$321,551.82Shares × reported price
Shares traded
1,002Common Stock
Price per share
$320.91Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
66,296Direct
Trade date
Nov 15, 2026Tax withholding
Filed
Nov 17, 2026, 7:38 PM ET3-day reporting delay
Accession
0001751980-26-000006Code F · Transaction 404885
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Grant3,120$0.00$0Trade 404886
2 transaction rows in this filing. Joint filers share the same rows.

PEN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PEN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago −0.5%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs) granted to the Reporting Person. F2: A portion of these shares is subject to vesting. F3: On November 16, 2026, the Reporting Person was granted 3,120 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on November 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware Corporation, and Pinehurst Merger Sub, Inc., a Delaware Corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.